-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on CareTrust REIT, Raises Price Target to $46

Benzinga·11/11/2026 21:12:28
UBS analyst Michael Goldsmith maintains CareTrust REIT (NYSE:CTRE) with a Buy and raises the price target from $44 to $46.